Selective and sequential transarterial chemoembolization: survival in patients with hepatocellular carcinoma.

[1]  Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.  A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma , 2009 .

[2]  Ravi Murthy,et al.  Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. , 2007, Journal of vascular and interventional radiology : JVIR.

[3]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[4]  S. Goldberg,et al.  Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. , 2007, Journal of vascular and interventional radiology : JVIR.

[5]  E. Cholongitas,et al.  Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies , 2007, CardioVascular and Interventional Radiology.

[6]  J. Bruix,et al.  Chemoembolization for hepatocellular carcinoma. , 2004, Gastroenterology.

[7]  O. Matsui,et al.  Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate , 2004, Cancer Chemotherapy and Pharmacology.

[8]  M. Kusano,et al.  Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study) , 2004, Cancer Chemotherapy and Pharmacology.

[9]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[10]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[11]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[12]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[13]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[14]  J. Bruix,et al.  Prognosis of hepatocellular carcinoma. , 2002, Hepato-gastroenterology.

[15]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[16]  M. Rosen,et al.  Classifying complications of interventional procedures: a survey of practicing radiologists. , 2001, Journal of vascular and interventional radiology : JVIR.

[17]  J. Bruix,et al.  Prospective Validation of the Cancer of the Liver Italian Program (CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma , 2000, Hepatology.

[18]  Bellia Mario,et al.  Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .

[19]  O. Ernst,et al.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. , 1999, AJR. American journal of roentgenology.

[20]  J. Pignon,et al.  Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. , 1998, Journal of hepatology.

[21]  H. Ohishi,et al.  Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. , 1997, Seminars in oncology.

[22]  A. Roche,et al.  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. , 1990, Journal of hepatology.

[23]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.

[24]  S. Wallace,et al.  Chemoembolization: transcatheter management of neoplasms. , 1981, JAMA.

[25]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[26]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.